| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,221 |
5,967 |
$218K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,911 |
3,396 |
$174K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,300 |
2,654 |
$142K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,920 |
3,287 |
$73K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,381 |
931 |
$71K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
424 |
344 |
$50K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
208 |
142 |
$33K |
| 99215 |
Prolong outpt/office vis |
371 |
256 |
$30K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
975 |
812 |
$27K |
| 99205 |
Prolong outpt/office vis |
290 |
201 |
$18K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
224 |
202 |
$12K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,375 |
1,150 |
$11K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
484 |
370 |
$11K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
190 |
173 |
$9K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
19 |
15 |
$5K |
| 99406 |
|
729 |
578 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
371 |
263 |
$4K |
| 93000 |
|
282 |
257 |
$3K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
13 |
12 |
$3K |
| 99385 |
|
24 |
24 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,492 |
923 |
$1K |
| 99407 |
|
63 |
49 |
$987.36 |
| 99222 |
Initial hospital care, per day, moderate complexity |
14 |
12 |
$623.05 |
| 96127 |
|
517 |
349 |
$505.85 |
| 81003 |
|
247 |
220 |
$353.44 |
| 80053 |
Comprehensive metabolic panel |
88 |
82 |
$306.24 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
25 |
24 |
$191.35 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
325 |
162 |
$95.52 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
21 |
19 |
$60.10 |
| 36415 |
Collection of venous blood by venipuncture |
38 |
31 |
$49.56 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
166 |
104 |
$19.84 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
97 |
53 |
$3.36 |
| 3079F |
|
20 |
16 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
62 |
50 |
$0.00 |
| 3074F |
|
17 |
14 |
$0.00 |
| 1170F |
|
14 |
14 |
$0.00 |
| 3288F |
|
55 |
49 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
177 |
138 |
$0.00 |
| 2014F |
|
14 |
13 |
$0.00 |
| 3077F |
|
19 |
17 |
$0.00 |